ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.098,09
-0,50%
S&P 500
5.277,51
0,80%
US Dollar vs BRL
5,2463
0,00%
Bitcoin
67.487,42
-0,35%
Brent Oil
81,295
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Quoin Pharmaceuticals Ltd (QNRX)

  7. Quoin Pharmaceuticals Ltd (QNRX) Notícias

QNRX

Quoin Pharmaceuticals (QNRX)

Quoin Pharmaceuticals Ltd
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:QNRX
DataHoraFonteTítuloCódigoCompanhia
10/05/202417:10Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:QNRXQuoin Pharmaceuticals Ltd
09/05/202409:30GlobeNewswire Inc.Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2024 Financial ResultsNASDAQ:QNRXQuoin Pharmaceuticals Ltd
02/05/202417:10GlobeNewswire Inc.Quoin Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 9, 2024NASDAQ:QNRXQuoin Pharmaceuticals Ltd
13/03/202417:05GlobeNewswire Inc.Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial ResultsNASDAQ:QNRXQuoin Pharmaceuticals Ltd
13/03/202408:03IH Market NewsMixed Futures Amidst Quiet Economic Schedule; Oil Prices ClimbNASDAQ:QNRXQuoin Pharmaceuticals Ltd
08/03/202418:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QNRXQuoin Pharmaceuticals Ltd
07/03/202418:05GlobeNewswire Inc.Quoin Pharmaceuticals Announces Fourth Quarter and 2023 Financial Results and Corporate Update Conference Call to be held on Thursday March 14th at 8:30 am ETNASDAQ:QNRXQuoin Pharmaceuticals Ltd
06/03/202419:07Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:QNRXQuoin Pharmaceuticals Ltd
05/03/202410:00GlobeNewswire Inc.Quoin Pharmaceuticals Announces Pricing of $6.5 Million Public OfferingNASDAQ:QNRXQuoin Pharmaceuticals Ltd
04/03/202410:00GlobeNewswire Inc.Quoin Pharmaceuticals Announces FDA Clearance to Recruit Teen Subjects into Both Ongoing Netherton Syndrome Clinical StudiesNASDAQ:QNRXQuoin Pharmaceuticals Ltd
27/02/202408:01Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:QNRXQuoin Pharmaceuticals Ltd
15/02/202402:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:QNRXQuoin Pharmaceuticals Ltd
13/02/202422:11Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:QNRXQuoin Pharmaceuticals Ltd
13/02/202418:50Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:QNRXQuoin Pharmaceuticals Ltd
13/02/202418:30Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:QNRXQuoin Pharmaceuticals Ltd
12/02/202419:12Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:QNRXQuoin Pharmaceuticals Ltd
08/02/202410:00GlobeNewswire Inc.Quoin Pharmaceuticals Files U.S. and International Patent Applications for Novel Netherton Syndrome Combination ProductNASDAQ:QNRXQuoin Pharmaceuticals Ltd
13/12/202310:30GlobeNewswire Inc.Quoin Pharmaceuticals Announces FDA Clearance of Clinical Optimization Plan for QRX003 for Netherton SyndromeNASDAQ:QNRXQuoin Pharmaceuticals Ltd
09/11/202319:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:QNRXQuoin Pharmaceuticals Ltd
08/11/202319:46GlobeNewswire Inc.Quoin Pharmaceuticals Provides Corporate Update and Announces Third Quarter 2023 Financial ResultsNASDAQ:QNRXQuoin Pharmaceuticals Ltd
03/11/202309:41GlobeNewswire Inc.Quoin Pharmaceuticals Announces Third Quarter 2023 Financial Results and Corporate Update Conference Call to be held on Thursday November 9th at 8:30 am ETNASDAQ:QNRXQuoin Pharmaceuticals Ltd
30/10/202317:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QNRXQuoin Pharmaceuticals Ltd
24/10/202310:32GlobeNewswire Inc.REPEAT -- Quoin Pharmaceuticals Announces Additional Positive Clinical Data from Open-Label, Single-Arm Clinical Trial in Netherton SyndromeNASDAQ:QNRXQuoin Pharmaceuticals Ltd
24/10/202309:28GlobeNewswire Inc.Quoin Pharmaceuticals Announces Additional Positive Clinical Data from Open-Label, Single-Arm Clinical Trial in Netherton SyndromeNASDAQ:QNRXQuoin Pharmaceuticals Ltd
19/10/202318:00Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:QNRXQuoin Pharmaceuticals Ltd
12/09/202307:04Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:QNRXQuoin Pharmaceuticals Ltd
02/08/202317:45GlobeNewswire Inc.Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2023 Financial ResultsNASDAQ:QNRXQuoin Pharmaceuticals Ltd
27/07/202309:00GlobeNewswire Inc.Quoin Pharmaceuticals Announces Second Quarter 2023 Financial Results and Corporate Update Conference Call to be held on Thursday August 3rd at 8:30 am ETNASDAQ:QNRXQuoin Pharmaceuticals Ltd
14/07/202318:06Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:QNRXQuoin Pharmaceuticals Ltd
28/06/202316:04Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:QNRXQuoin Pharmaceuticals Ltd
 Apresentando as notícias mais relevantes sobre:NASDAQ:QNRX

Seu Histórico Recente

BIT
P17RD5
BNP Paribas Issuance
BIT
UIG366
Unicredit Bank
LSE
BPFI
Blue Planet Gw&inc I.T.5
LSE
AU50
Ex-im Korea 27
USOTC
POMOF
Me (PK)
EU
BEB157651857
Euronext VPU Public Auct...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados